Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 41-45 , March 2009

How we treat Bowen's disease with topical photodynamic therapy in Dundee

References 

  1. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Br J Dermatol. 2008;159(December (6)):1245–1266
  2. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol. 2006;142(June (6)):729–735
  3. Ibbotson SH, Moseley H, Brancaleon L, et al. Photodynamic therapy in dermatology: Dundee clinical and research experience. Photodiagn Photodyn Ther. 2004;1:211–223
  4. Moseley H, Ibbotson S, Woods J, et al. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre. Lasers Surg Med. 2006;38(June (5)):403–416
  5. Moseley H, Brancaleon L, Lesar AE, et al. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?. Photodermatol Photoimmunol Photomed. 2008;24:72–75
  6. Ibbotson SH. How we treat a superficial basal cell carcinoma with topical photodynamic therapy in Dundee. Photodiag Photodyn Therapy. 2006;3:128–131
  7. Hewett J, Nadeau V, Ferguson J, et al. The application of a compact multispectral imaging system with integrated excitation source to in vivo monitoring of fluorescence during topical photodynamic therapy of superficial skin cancers. Photochem Photobiol. 2001;73(3):278–282
  8. Ibbotson SH, Jong C, Lesar A, et al. Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatol Photoimmunol Photomed. 2006;22(April (2)):105–110
  9. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomised, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol. 2004;150:337–340
  10. Clark C, Bryden AM, Dawe RS, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photoderm Photoimmunol Photomed. 2003;19:134–141
  11. Moseley H, Allen JW, Ibbotson S, et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Br J Dermatol. 2006;154:747–750
  12. Attili SK, Lesar A, McNeill A, et al. An open pilot study of ambulatory photodynamic therapy (PDT) using a wearable low-irradiance organic LED light source in the treatment of non melanoma skin cancer. Br J Dermatol; in press.
  13. Clark C, Dawe RS, Moseley H, Ferguson J, Ibbotson SH. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed. 2004;20(2):105–107
  14. Kerr AC, Ferguson J, Ibbotson SH. Acute phototoxicity with urticarial features during topical 5-aminolaevulinic acid. photodynamic therapy. Clin Exp Dermatol. 2007;32(2):201–202
  15. Attili SK, Murgatroyd H, Ibbotson SH, Fleming CJ. Role of non-surgical therapies in the management of periocular malignancy: a case series. EADV. 2008;(abstract)

PII: S1572-1000(09)00033-7

doi: 10.1016/j.pdpdt.2009.04.001

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 41-45 , March 2009

Article Tools

* Image Usage & Resolution